PENGEMBANGAN DAN PENGGUNAAN APLIKASI ANDROID SEBAGAI SOLUSI INOVATIF DALAM PENGGUNAAN OBAT PASIEN HIV DI KOTA BANDUNG DAN SEKITARNYA

• Main Author: Irwan, Mariana
• Format: Final Project
• Language: Indonesia
• Online Access: https://digilib.itb.ac.id/gdl/view/43930
• Institution: Institut Teknologi Bandung

Human Immunodeficiency Virus (HIV) is a virus that spreads through body fluids and targets on immune system, especially CD4 cells (T helper cells). The latest stage of HIV infection is called the Acquired Immunodeficiency Syndrome (AIDS). Antiretroviral (ARV) is a therapy that is given to the patients with HIV positive. Indonesia is the 13 th highest country in the world of HIV/AIDS patients in the world and West Java is the fourth highest HIV cases in Indonesia. Among the groups of infectious diseases, the burden of diseases caused by HIV was the highest increase of 21.15%. Factors that influence inadherence of HIV patients in the use of ARV therapy are the internal factors include: knowledge, behavior, self-image, consideration of cost and time losses during treatment, demographics, and attitudes towards treatment. While the external factors include: limited access of communication with health professional, drug regimens (duration of treatment, side effects, the number of drugs that need to be consumed, etc.), social support from health workers or family, and the presence of Drugs Supervisors (PMO). Flo. Apps developed with the aim of helping HIV patients and the general public to get information about HIV-AIDS and access to pharmacists as drug therapy monitoring and help HIV patients to be adherence in ARV regimen with alarms and reminders of visits to health service providers that serve HIV. Within 30 days of usage, there are 80.41% of HIV patient users who accessed apps online at least three times. In short, Flo. Apps has given direct benefits to both users of patient groups and general public groups. This search shows the satisfaction level of service quality that Flo. has presented is counted to reach 93.99 ± 2.64% with CV value reach at 2.80%.